Publications by authors named "Tasneem Farhad"
Genes (Basel)
October 2022
Article Synopsis
- Adenoviral vaccines have gained prominence in combating pandemics like Ebola and COVID-19, leading to renewed interest in their use against other significant viruses, including hepatitis B virus (HBV).
- Current treatments for hepatitis B are not curative, posing serious health risks such as liver disease and mortality for those infected.
- The strengths of adenoviral vectors—specifically their ability to provoke strong immune responses and effectively target the liver—make them promising candidates for developing vaccines and therapies against HBV.
